vTv Therapeutics Inc.

Overview

vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing new orally administered treatments for human diseases. The company primarily focuses on therapies for neurological pathology, metabolic disorders, and inflammatory diseases.

Therapeutic areas

API / Drug Master Files

vTv Therapeutics Inc. holds 1 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• CARBACHOL DRUG SUBSTANCEActive2025-03-20

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to vTv Therapeutics Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.